These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 18493227)

  • 1. The prevention of type 2 diabetes.
    Crandall JP; Knowler WC; Kahn SE; Marrero D; Florez JC; Bray GA; Haffner SM; Hoskin M; Nathan DM;
    Nat Clin Pract Endocrinol Metab; 2008 Jul; 4(7):382-93. PubMed ID: 18493227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?
    Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP
    Curr Pharm Des; 2010; 16(34):3939-847. PubMed ID: 21128892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of β-cell function: the key to diabetes prevention.
    DeFronzo RA; Abdul-Ghani MA
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2354-66. PubMed ID: 21697254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the pharmacotherapy options for treating prediabetes?
    Daniele G; Abdul-Ghani M; DeFronzo RA
    Expert Opin Pharmacother; 2014 Oct; 15(14):2003-18. PubMed ID: 25139488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle and medication interventions for the prevention or delay of type 2 diabetes mellitus in prediabetes: a systematic review of randomised controlled trials.
    Yuen A; Sugeng Y; Weiland TJ; Jelinek GA
    Aust N Z J Public Health; 2010 Apr; 34(2):172-8. PubMed ID: 23331362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological strategies for preventing type 2 diabetes in patients with impaired glucose tolerance.
    Smith-Marsh D
    Drugs Today (Barc); 2013 Aug; 49(8):499-507. PubMed ID: 23977667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention.
    Hostalek U; Gwilt M; Hildemann S
    Drugs; 2015 Jul; 75(10):1071-94. PubMed ID: 26059289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reflecting on type 2 diabetes prevention: more questions than answers!
    Rosenstock J
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of type 2 diabetes in the prediabetic population.
    Maji D; Roy RU; Das S
    J Indian Med Assoc; 2005 Nov; 103(11):609-11. PubMed ID: 16570766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes.
    Roberts S; Barry E; Craig D; Airoldi M; Bevan G; Greenhalgh T
    BMJ Open; 2017 Nov; 7(11):e017184. PubMed ID: 29146638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of diabetes: a strategic approach for individual patients.
    Shin JA; Lee JH; Kim HS; Choi YH; Cho JH; Yoon KH
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():79-84. PubMed ID: 23280871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should Adults with Prediabetes Be Prescribed Metformin to Prevent Diabetes Mellitus? No: Evidence Does Not Show Improvements in Patient-Oriented Outcomes.
    Brown SR
    Am Fam Physician; 2019 Aug; 100(3):136-138. PubMed ID: 31361107
    [No Abstract]   [Full Text] [Related]  

  • 14. Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.
    Goldberg RB; Temprosa M; Mele L; Orchard T; Mather K; Bray G; Horton E; Kitabchi A; Krakoff J; Marcovina S; Perreault L; White N;
    Metabolism; 2016 May; 65(5):764-775. PubMed ID: 27085783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained.
    Olchanski N; van Klaveren D; Cohen JT; Wong JB; Ruthazer R; Kent DM
    Acta Diabetol; 2021 Jun; 58(6):707-722. PubMed ID: 33517494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes prevention programs.
    Ramachandran A; Snehalatha C
    Med Clin North Am; 2011 Mar; 95(2):353-72, viii. PubMed ID: 21281838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causal Effects of Intensive Lifestyle and Metformin Interventions on Cardiovascular Disease Risk Factors in Pre-Diabetic People: An Application of G-Estimation.
    Salimi Y; Fotouhi A; Mohammad K; Mansournia N; Mansournia MA
    Arch Iran Med; 2017 Jan; 20(1):55-59. PubMed ID: 28112533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
    Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
    Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to prevent type 2 diabetes.
    Abuissa H; Bel DS; O'keefe JH
    Curr Med Res Opin; 2005 Jul; 21(7):1107-14. PubMed ID: 16004680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions.
    Stevens JW; Khunti K; Harvey R; Johnson M; Preston L; Woods HB; Davies M; Goyder E
    Diabetes Res Clin Pract; 2015 Mar; 107(3):320-31. PubMed ID: 25638454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.